Valvular Calcific Deposits and Mortality in Peritoneal Dialysis Patients: A Propensity Score-Matched Cohort Analysis

Author:

Shen Aiwen,Jiang Linsen,Tian Yunhuan,Lu Ying,Wang Zhi,Shen Huaying,Song Kai,Feng Sheng

Abstract

<b><i>Objective:</i></b> This study aimed to compare mortality between peritoneal dialysis (PD) patients with and without cardiac valve calcification (CVC). <b><i>Methods:</i></b> Patients undergoing PD at the dialysis center of the Second Affiliated Hospital of Soochow University from January 1, 2009, to June 31, 2016, were included and followed through December 31, 2018. The inclusion criteria were (1) age ≥18 years and (2) PD vintage ≥1 month. The exclusion criteria were (1) a history of hemodialysis or renal transplantation before PD; (2) diagnosed congenital heart disease, rheumatic heart disease, or hyperthyroid heart disease; and (3) loss to follow-up. Differences in mortality rates were compared using a Fine-Gray proportional hazards model. <b><i>Results:</i></b> A total of 310 patient cases were included in this study, including 237 cases without CVC (non-CVC group). The CVC group included 59 cases with aortic valve calcification (AVC), 6 cases with mitral valve calcification (MVC), and 8 cases of AVC associated with MVC. After propensity score matching, 68 pairs were selected. The multivariate competing risk regression analysis revealed that age (hazard ratio [HR]: 1.06, 95% confidence interval [95% CI]: 1.03–1.10, <i>p</i> &#x3c; 0.001) and CVC group (HR: 1.83, 95% CI: 1.04–3.20, <i>p</i> &#x3c; 0.05) were independent risk factors associated with mortality. No significant difference was observed in technique survival between the 2 groups. <b><i>Conclusion:</i></b> CVC is an independent risk factor for mortality in PD patients.

Publisher

S. Karger AG

Subject

Urology,Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Chen NX, Srinivasan S, O’Neill K, Nickolas TL. Effect of advanced glycation end-products (AGE) lowering drug ALT-711 on biochemical, vascular, and bone parameters in a rat model of CKD-MBD. J Bone Miner Res. 2020;35(3):608–17.

2. Cianciolo G, La Manna G, Capelli I, Gasperoni L, Galassi A, Ciceri P, et al. The role of activin: the other side of chronic kidney disease-mineral bone disorder? Nephrol Dial Transplant. 2020.

3. Chen NX, Moe SM. Pathophysiology of vascular calcification. Curr Osteoporos Rep. 2015;13(6):372–80.

4. Viegas C, Araújo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in chronic kidney disease (CKD): challenging old concepts with new facts. Aging. 2019;11(12):4274–99.

5. Jegatheesan D, Cho Y, Johnson DW. Clinical studies of interventions to mitigate cardiovascular risk in peritoneal dialysis patients. Semin Nephrol. 2018;38(3):277–90.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3